Practical Derm

Happy Mother’s Day to the women who care for patients, families, communities, and each other every single day. 💐Today, we celebrate the mothers of dermatology—including dermatologists, residents, physician assistants, nurse practitioners, nurses, researchers, and healthcare professionals whose compassion extends far beyond the clinic. Your dedication, resilience, and leadership continue to inspire both your patients and colleagues alike. We also recognize those hoping to become mothers, those navigating loss, and anyone carrying complex emotions today. You are valued, supported, and seen. 🤍 From all of us at Practical Dermatology, thank you for the care, empathy, and healing you bring to the specialty and to the people who depend on you every day. #MothersDay #PracticalDermatology #WomenInDermatology #HealthcareHeroes #DermatologyCommunity #WomenInMedicine #MothersDay2026

📊🔎 VITILIGO CARE DISPARITIES: Nearly 1 in 3 patients with #vitiligo received no treatment after diagnosis in a new JAMA Dermatology cohort study of 24,949 patients. Treatment duration was also short, highlighting ongoing management challenges. ➡️ ow.ly/qJqY50YWIQc #Vitiligo #Dermatology #SkinHealth #DermResearch

📢📰NEWS: A new PEDSnet study indicates Black children had higher frequencies of AD, acne, and HS but lower dermatology specialty care use across all 5 studied conditions ➡️ ow.ly/TORu50YWnEr #ChildSkinCare #Dermatology #EczemaTreatment #HealthySkin #PediatricDermatology #EczemaAwareness #skinofcolor

🎙️ 👨‍⚕️👨‍⚕️ SCIENCE OF SKIN PODCAST: In this episode of The Science of Skin Podcast, Practical Dermatology Editorial Board member and Science of Skin Summit Co-founder Edward (Ted) Lain, MD, MBA, is joined by Steven Daveluy, MD, FAAD, to discuss the complicated pathophysiology of hidradenitis suppurativa and the future of treatment capabilities for the disease. 🎧 Listen to the full epispode here ➡️ ow.ly/oIOj50YVygn #HidradenitisSuppurativa #SkinScience #SkinHealth #PracticalDermatologyPodcast #Dermatology #HSAwareness

📢NEW: Topical N-acetylcysteine (NAC) plus doxycycline was associated with greater improvement than benzoyl peroxide (BPO) plus doxycycline in patients with moderate acne vulgaris, according to findings from a double-blind randomized clinical trial ➡️ ow.ly/iC6250YVxLs #AcneVulgaris #SkinHealth #Doxycycline #Dermatology

🎤🤵‍♂️C-SUITE CHAT: Cosmo Pharmaceuticals CEO Giovanni Di Napoli discusses the challenges posed by androgenetic alopecia (AGA) and the potential impact of a clascoterone 5% topical solution based on new Phase 3 data. Watch here ➡️ ow.ly/UrAf50YUqB6 #Pharmaceuticals #CosmoPharmaceuticals #AndrogeneticAlopecia #HairLossTreatment #Dermatology

🔎💇‍♀️HAIR LOSS FOCUS: Practical Dermatology Editorial Board member Amy Spizuoco, DO, FAOCD, FAAD, previews the upcoming meeting that she co-founded, the DermVIP Summit, which will focus hair loss and scalp conditions along with inflammatory skin diseases ➡️ ow.ly/KNC350YTSeJ #HairLoss #Dermatology #ScalpHealth #InflammatorySkin #DermVIPSummit #HairCare

👀 📊 NEW: A melanoma PRS improved prediction beyond clinical factors alone, raising MP16 discrimination from 0.713 to 0.729 in QSkin ➡️ ow.ly/IgXO50YT0p0 #Dermatology #Melanoma #PrecisionMedicine #SkinCancerAwareness

🎤👩‍⚕️ON SCENE: At the 67th Noah Worcester Dermatological Society Annual Meeting, Practical Dermatology Associate Medical Editor Lisa Swanson, MD, FAAD, delivered the Alfred L. Weiner Lecture titled “Afraid to Treat Kids? Here are some Pearls to Help!” focusing on practical, clinic-ready strategies to improve care for pediatric patients, emphasizing communication, therapeutic updates, and clinician confidence. Read more ➡️ ow.ly/RRuC50YRZcE #Dermatology #PediatricDermatology #SkinCare #PediatricCare

🚨NEW: Povorcitinib hits Phase 3 endpoints in vitiligo (P < .001), while HS and AD programs advance. Busy pipeline ahead for Incyte ➡️ ow.ly/Ls8250YRxnZ #dermatology #vitiligo #hidradenitissuppurativa #aesthetics #clinicaltrials

🧴📊 BPO SAFETY UPDATE: Meta-analysis of >4M patients shows no significant association with leukemia, AML, lymphoma, or hematologic malignancy ➡️ ow.ly/JpQ050YQPQn #dermatology #acne #patientsafety #BPO #cancerawareness #skincancer #mednews

🤖🔎🩺 AI AFFECTING PATIENT UNDERSTANDING: AI skin apps may boost patient diagnostic accuracy vs web search (22.8% vs 7.9%). But accuracy depends on quality of predictions. JAMA Dermatology study highlights both promise and gaps. #Dermatology #AI #DigitalHealth ➡️ ow.ly/4qG350YQ0nc #Dermatology #DigitalHealth #AIinMedicine #SkinHealth #HealthTech

🩺📊ON DEFINING REMISSION IN AD: Global experts recently defined what “remission” really means in eczema care, in a move toward standardizing outcomes for better trials and treatment goals ➡️ ow.ly/Vhv150YQ0ll #eczema #atopicdermatitis #dermatology #skincaretech #AtopicDermatitis #DermTwitter

🚨ALERT: FDA finds 6 more gel nail removers with banned methylene chloride. Labeling inconsistencies raise safety concerns. Read which products are affected ➡️ ow.ly/XVhr50YPjVY #DermNews #FDA #Cosmetics

📢NEW: Ultrasound & CT bested physical exam for nodal staging in high-risk #cSCC—but sensitivity dropped sharply in immunosuppressed patients ➡️ ow.ly/g7hM50YOQf6 #Dermatology #SkinCancer #Imagine #ComputedTomography #cSCC

📢 👀 APRIL ISSUE NOW LIVE: The April 2026 issue of Practical Dermatology is now live - delve into a focused, expert-driven examination of issues surrounding acne and rosacea 👉 ow.ly/AJfs50YOjZS #dermatology #acne #rosacea #skin #skinhealth

🛑 CKD COMPLICATES POST-MOHS RECOVERY: Chronic kidney disease (CKD) was associated with increased postoperative complications following Mohs micrographic surgery (MMS) ➡️ ow.ly/JANV50YN964 #ChronicKidneyDisease #CKD #MohsSurgery #DermatologyResearch

🔎📊 PDT VS. CRYO FOR ACTINIC KERATOSIS: A recent systematic review and meta-analysis suggested comparable efficacy and safety of photodynamic therapy (PDT) and cryotherapy for lesion clearence in actinic keratosis ➡️ ow.ly/1r5r50YMhTC #Dermatology #ActinicKeratosis

👀🧴🩺 What’s Next for Pediatric AD: Larry Eichenfield, MD, talks about the recent INTEGUMENT-OLE data and the impact of the roflumilast cream 0.05% (Zoryve) on the treatment of mild-to-moderate AD in children aged 2 to 5 years ➡️ ow.ly/2kTj50YMgzm

DEFINITIONS MATTER: The International Eczema Council (IEC) defines LDA, vLDA, and remission in AD—bringing much-needed standardization to trials and practice ➡️ ow.ly/evFS50YLpyl #Eczema #Dermatology #SkinHealth #AtopicDermatitis #EczemaAwareness #DermTwitter